Dormant origins, the licensing checkpoint, and the response to replicative stresses
Related Experiment Video
Updated: May 19, 2026

G2-seq: A High Throughput Sequencing-based Technique for Identifying Late Replicating Regions of the Genome
Published on: March 22, 2018
Debbie McIntosh1, J Julian Blow
1Centre for Gene Regulation & Expression, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.
Abstract:
Only ∼10% of replication origins that are licensed by loading minichromosome maintenance 2-7 (MCM2-7) complexes are normally used, with the majority remaining dormant. If replication fork progression is inhibited, nearby dormant origins initiate to ensure that all of the chromosomal DNA is replicated. At the same time, DNA damage-response kinases are activated, which preferentially suppress the assembly of new replication factories. This diverts initiation events away from completely new areas of the genome toward regions experiencing replicative stress. Mice hypomorphic for MCM2-7, which activate fewer dormant origins in response to replication inhibition, are cancer-prone and are genetically unstable. The licensing checkpoint delays entry into S phase if an insufficient number of origins have been licensed. In contrast, humans with Meier-Gorlin syndrome have mutations in pre-RC proteins and show defects in cell proliferation that may be a consequence of chronic activation of the licensing checkpoint.
Insights
Most DNA replication origins remain dormant. When replication is blocked, dormant origins activate, but this process is tightly regulated to prevent genomic instability and cancer. Meier-Gorlin syndrome highlights defects in this regulation.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Only a small fraction of licensed DNA replication origins are actively used during S phase.
- Dormant origins are activated upon replication stress to ensure complete genome duplication.
- DNA damage response pathways regulate replication origin firing to prevent genomic instability.
Purpose of the Study:
- To investigate the regulation and function of dormant DNA replication origins.
- To understand the role of minichromosome maintenance (MCM2-7) complexes in origin licensing and activation.
- To explore the consequences of impaired dormant origin activation in disease models.
Main Methods:
- Analysis of replication origin usage under normal and inhibited conditions.
- Investigation of DNA damage response kinase activation during replication stress.
- Study of mouse models with altered MCM2-7 complex levels.
- Examination of human genetic disorders affecting replication origin regulation.
Main Results:
- Replication fork inhibition triggers dormant origin activation and suppresses new replication factory assembly.
- Mice with reduced MCM2-7 complexes exhibit increased cancer susceptibility and genetic instability due to insufficient dormant origin activation.
- The licensing checkpoint delays S phase entry when origin licensing is insufficient.
Conclusions:
- Dormant origin activation is a critical mechanism for maintaining genome integrity during replication stress.
- Dysregulation of dormant origin activation contributes to cancer predisposition and genetic instability.
- Defects in pre-replication complex proteins, as seen in Meier-Gorlin syndrome, can lead to cell proliferation defects via licensing checkpoint activation.
Related Concept Videos
Restarting Stalled Replication Forks
Restarting Stalled Replication Forks
The DNA Replication Fork
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes
Replication in Eukaryotes

